Medscape Conference Coverage, based on selected sessions at the:

American College of Rheumatology (ACR) 2008 Annual Scientific Meeting

October 24 - 29, 2008; San Francisco, California

This activity is not sanctioned by, nor a part of, the American College of Rheumatology. Conference news does not receive grant support and is produced independently.

Conference News

  • Certolizumab in Rheumatoid Arthritis Patients

    Analyses of the double-blind randomized controlled RAPID 1 and RAPID 2 trials show long-term improvements in physical function and pain.
    Medscape Medical News, October 31, 2008
  • Two New Osteoporosis Drugs Increase BMD

    Teriparatide may be an option for patients with glucocorticoid-induced osteoporosis, and denosumab increased bone mass in postmenopausal women.
    Medscape Medical News, October 30, 2008
  • Pain Relief in Moderate to Severe Osteoarthritis

    A phase 2 trial of tanezumab showed improvements in pain, but adverse effects include paresthesia.
    Medscape Medical News, October 29, 2008
  • Rheumatoid Arthritis Diagnosis the Biggest Factor in Increased MI Risk

    Treating both the underlying disease and traditional myocardial infarction risk factors are both crucial, but having a diagnosis of RA was the strongest influence on MI risk.
    Medscape Medical News, October 28, 2008
  • Tadalafil Reduces Raynaud's Episodes

    In the first randomized controlled trial of its kind, the drug tadalafil reduced the duration and frequency of secondary Raynaud's phenomenon episodes in patients with scleroderma and mixed connective-tissue disease.
    Medscape Medical News, October 27, 2008

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American College of Rheumatology. These materials and the related activity are not sanctioned by the American College of Rheumatology or the commercial supporter of the conference and do not constitute an official part of that conference.